Records containing: Melanoma (Skin)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-06-14Phase II Evaluation of Peptide Immunization and LMB-2 in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-05-02An Evaluation of the Tissue Distribution and the Selective Tumor Trafficking of TNF-Bound Colloidal Gold (CYT-6091) Following Intravenous Administration in Subjects With Primary and Metastatic Cancer Undergoing Surgical Resection
-
CLINICAL_TRIALS study record update · 2012-03-30Releasing the Cancer Patient's Immune System From Down-regulation With Timed Delivery of Standard Chemotherapy
-
CLINICAL_TRIALS study record update · 2012-03-29Phase II Trial Using Aldesleukin (IL-2) Following a Lymphodepleting Chemotherapy and Reinfusion of Autologous Lymphocytes Depleted of T Regulatory Lymphocytes in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-03-15A PHASE I STUDY OF THE COMBINATION OF CAI AND PACLITAXEL IN ADULT PATIENTS WITH REFRACTORY CANCERS OR LYMPHOMA
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-03-15A Study in Metastatic Melanoma Using a Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 TCR-Gene Engineered Lymphocytes and Subsequent Peptide Immunization
-
CLINICAL_TRIALS study record update · 2012-03-15PET/CT Evaluation of Subjects Treated on Surgery Branch Adoptive Cell Therapy Protocols
-
CLINICAL_TRIALS study record update · 2012-01-13A Phase II Trial of Complete Surgical Resection For Stage IV Melanoma -- Surgical Resection With Biological Evaluation and Clinical Follow-Up
-
CLINICAL_TRIALS study record update · 2011-11-30Phase II Trial of Non-Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation Using Fludarabine, Low-Dose TBI, and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil (MMF) Followed by Donor Lymphocyte Infusion in Selected Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-11-16POST-OPERATIVE ADJUVANT INTERFERON-ALFA-2B (INTRON-A) TREATMENT AFTER RESECTION OF THICK PRIMARY MELANOMA AND/OR REGIONAL LYMPHNODE METASTASES 'INTERMEDIATE-HIGH DOSE' VS INTERMEDIATE-LOW DOSE' IFN-ALFA VS OBSERVATION: A 3-ARM MULTICENTER RANDOMIZED PHASE III TRIAL
-
CLINICAL_TRIALS study record update · 2011-11-08Phase II Evaluation of Immunization With an HLA-A2 Multi-Epitope Peptide Vaccine Containing MART-1 (NSC #672643), gp100 (NSC #683472), and Tyrosinase (NSC #699048) Peptides Alone or in Combination With GM-CSF, IFN Alpha-2b, or GM-CSF + IFN Alpha-2b in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-08-03Phase I Study of Flavopiridol in Combination With Cisplatin in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2011-06-07A Phase Ia/Ib Study of the Safety and Immunogenicity of a Xenogeneic Tyrosinase DNA Vaccine Melanoma
-
CLINICAL_TRIALS study record update · 2011-05-16A Phase II Study of Anti-angiogenesis Therapy for Metastatic Melanoma Using ABT-510
-
CLINICAL_TRIALS study record update · 2011-05-12Treatment of Metastatic Renal Cell Carcinoma and Melanoma With Subsequential High-Dose Subcutaneous Interferon Alfa-2b and High-Dose Bolus and Continuous Intravenous Interleukin-2
-
CLINICAL_TRIALS study record update · 2011-05-12A Phase I/II Pilot Study Of Intranodal Delivery Of A Plasmid DNA (Synchrovax SEM Vaccine) In Stage IV Melanoma Patients
-
CLINICAL_TRIALS study record update · 2011-05-11ALPHA INTERFERON, TUMOR INFILTRATING LYMPHOCYTES, AND INTERLEUKIN-2 IN THE TREATMENT OF CANCER
-
CLINICAL_TRIALS study record update · 2011-05-10Phase I Study of Paclitaxel (Taxol) and Bortezomib (Velcade) in Patients With Refractory Solid Tumor Malignancies Involving an Activated MAPK Pathway
-
CLINICAL_TRIALS study record update · 2010-10-07Open-label, Single Center, Uncontrolled Phase I/II Study Evaluating the Safety and Maximum Tolerated Dose of Daily Sorafenib Administered in Combination With Prolonged Temozolomide in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-09-21Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD4+ Antigen-Specific T Cell Clones for Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-08-06Single Patient Study to Evaluate Cellular Adoptive Immunotherapy Using Autologous Lymphocytes Following Cyclophosphamide Conditioning for a Single Patient With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-05-10PHASE I STUDY TO EVALUATE THE SAFETY OF CELLULAR ADOPTIVE IMMUNOTHERAPY USING GENETICALLY MODIFIED AND UNMODIFIED AUTOLOGOUS CD8+ TYROSINASE-SPECIFIC T CELLS FOR PATIENTS WITH METASTATIC MELANOMA
-
CLINICAL_TRIALS study record update · 2010-05-07Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen Specific T Cell Clones Targeting Cancer Testis Antigens for Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2009-12-11A Phase 0 Trial of Riluzole in Patients With Resectable Stage III and IV Melanoma
-
CLINICAL_TRIALS study record update · 2009-02-09A Randomized Phase II Study of Immunization Against Melanoma Comparing Autologous Dendritic Cells Pulsed With gp100 Peptide to Autologous Dendritic Cells Fused With Autologous Tumor Cells